The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Open accessAbstract
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment of drug-susceptible tuberculosis, which is also endorsed by the European Respiratory Society and the US National Tuberculosis Controllers Association. Representatives from the American Academy of Pediatrics, the Canadian Thoracic Society, the International Union Against Tuberculosis and Lung Disease, and the World Health Organization also participated in the development of the guideline. This guideline provides recommendations on the clinical and public health management of tuberculosis in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis. For all recommendations, literature reviews were performed, followed by discussion by an expert committee according to the Grading of Recommendations, Assessment, Development and Evaluation methodology. Given the public health implications of prompt diagnosis and effective management of tuberculosis, empiric multidrug treatment is initiated in almost all situations in which active tuberculosis is suspected. Additional characteristics such as presence of comorbidities, severity of disease, and response to treatment influence management decisions. Specific recommendations on the use of case management strategies (including directly observed therapy), regimen and dosing selection in adults and children (daily vs intermittent), treatment of tuberculosis in the presence of HIV infection (duration of tuberculosis treatment and timing of initiation of antiretroviral therapy), as well as treatment of extrapulmonary disease (central nervous system, pericardial among other sites) are provided. The development of more potent and better-tolerated drug regimens, optimization of drug exposure for the component drugs, optimal management of tuberculosis in special populations, identification of accurate biomarkers of treatment effect, and the assessment of new strategies for implementing regimens in the field remain key priority areas for research. See the full-text online version of the document for detailed discussion of the management of tuberculosis and recommendations for practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The Impact of Medical Interpreter Services on the Quality of Health Care: A Systematic Review
Flores, G. (2005) · Medical Care Research and Review · doi:10.1177/1077558705275416 · Cited by 1,667
Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults
Thwaites, G. E., Bang, N. D., Dung, N. H., Quy, H. T., Oanh, D. T. T., Thoa, N. T. C., Hien, N. Q., Thuc, N. T., Hai, N. N., Lan, N. T. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040573 · Cited by 1,043
An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy
Saukkonen, J. J., Cohn, D. L., Jasmer, R. M., Schenker, S., Jereb, J. A., Nolan, C. M., Peloquin, C. A., Gordin, F. M., Nunes, D., Strader, D. B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1666st · Cited by 912
Self-citationThe impact of diabetes on tuberculosis treatment outcomes: A systematic review
Baker, M. A., Harries, A. D., Jeon, C. Y., Hart, J. E., Kapur, A., Lönnroth, K., Ottmani, S.-E., Goonesekera, S. D., & Murray, M. B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-81 · Cited by 881
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
Fox, W., Ellard, G. A., & MITCHISON, D. A. (1999) · PubMed · Cited by 676
Thwaites, G., Fisher, M., Hemingway, C., Scott, G., Solomon, T., & Innes, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.011 · Cited by 666
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Gillespie, S. H., Crook, A. M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murray, S. R., Pappas, F., Phillips, P. P. J., & Nunn, A. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407426 · Cited by 645
Schünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
Corticosteroids for managing tuberculous meningitis
Prasad, K., Singh, M. B., & Ryan, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002244.pub4 · Cited by 534
Red Book 2015: Report of the Committee on Infectious Diseases
Kimberlin, D. W., Barnett, E. D., Lynfield, R., & Sawyer, M. H. (2015) · doi:10.1542/9781610025782 · Cited by 436
Wiktor, S. Z., Sassan-Morokro, M., Grant, A. D., Abouya, L., Karon, J. M., Maurice, C., Djomand, G., Ackah, A., Domoua, K., Kadio, A., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03465-0 · Cited by 418
Meintjes, G., Wilkinson, R. J., Morroni, C., Pepper, D. J., Rebe, K., Rangaka, M. X., Oni, T., & Maartens, G. (2010) · AIDS · doi:10.1097/qad.0b013e32833dfc68 · Cited by 405
International Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Self-citationVernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Self-citationSchoeman, J. F., Van Zyl, L. E., Laubscher, J. A., & Donald, P. R. (1997) · Pediatrics · doi:10.1542/peds.99.2.226 · Cited by 300
Masur, H., Brooks, J. T., Benson, C. A., Holmes, K. K., Pau, A. K., & Kaplan, J. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu094 · Cited by 269
Horne, D. J., Royce, S. E., Gooze, L., Narita, M., Hopewell, P. C., Nahid, P., & Steingart, K. R. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70071-2 · Cited by 259
Self-citationAdjunctive Corticosteroid Therapy for Tuberculosis: A Critical Reappraisal of the Literature
Dooley, D. P., Carpenter, J. L., & Rademacher, S. (1997) · Clinical Infectious Diseases · doi:10.1086/515543 · Cited by 259
Strang, J. I. G., Gibson, D. G., Mitchison, D. A., Girling, D. J., Kakaza, H. H. S., Allen, B. W., Evans, D. J., Nunn, A. J., & Fox, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92415-4 · Cited by 227
Weiner, M., Benator, D., Burman, W., Peloquin, C. A., Khan, A., Vernon, A., Jones, B., Silva-Trigo, C., Zhao, Z., Hodge, T., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429321 · Cited by 226
Self-citationMenzies, D., Benedetti, A., Paydar, A., Martin, I., Royce, S., Pai, M., Vernon, A., Lienhardt, C., & Burman, W. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000146 · Cited by 222
Self-citationStrang, J. I. G., Gibson, D. G., Nunn, A. J., Kakaza, H. H. S., Girling, D. J., & Fox, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91127-5 · Cited by 218
Dexamethasone adjunctive treatment for tuberculous meningitis
GIRGIS, N. I., FARID, Z., KILPATRICK, M. E., SULTAN, Y., & MIKHAIL, I. A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00002 · Cited by 217
Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 Months
Mitchison, D. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.1062 · Cited by 215
European Union Standards for Tuberculosis Care
Migliori, G. B., Zellweger, J. P., Abubakar, I., Ibraim, E., Caminero, J. A., De Vries, G., D'Ambrosio, L., Centis, R., Sotgiu, G., Menegale, O., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00203811 · Cited by 213
Self-citationCritchley, J. A., Young, F., Orton, L., & Garner, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70321-3 · Cited by 212
Corticosteroids for managing tuberculous meningitis
Prasad, K., & Singh, M. B. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002244.pub3 · Cited by 207
Menzies, D., Benedetti, A., Paydar, A., Royce, S., Pai, M., Burman, W., Vernon, A., & Lienhardt, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000150 · Cited by 194
Self-citationThe chemotherapy of tuberculosis: past, present and future [State of the art]
Mitchison, D., & Davies, G. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0083 · Cited by 185
Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial
Khan, A., Sterling, T. R., Reves, R., Vernon, A., Horsburgh, C. R., & and the Tuberculosis Trials Consortium (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1834oc · Cited by 185
Self-citationSmoking adversely affects treatment response, outcome and relapse in tuberculosis
Leung, C. C., Yew, W. W., Chan, C. K., Chang, K. C., Law, W. S., Lee, S. N., Tai, L. B., Leung, E. C. C., Au, R. K. F., Huang, S. S., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00114214 · Cited by 183
Hakim, J. G., Ternouth, I., Mushangi, E., Siziya, S., Robertson, V, & Malin, A. (2000) · Heart · doi:10.1136/heart.84.2.183 · Cited by 169
Sharma, S. K., Singla, R., Sarda, P., Mohan, A., Makharia, G. K., Jayaswal, A., Sreenivas, V., & Singh, S. (2010) · Clinical Infectious Diseases · doi:10.1086/650576 · Cited by 159
Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis
Burman, W. J., Benator, D., Vernon, A. A., Khan, A., Jones, B., Silva, C., Lahart, C., Weis, S. E., King, B., Mangura, B. T., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-417oc · Cited by 154
Self-citationA Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of Tuberculosis
Chang, K. C., Leung, C. C., Yew, W. W., Ho, S. C., & Tam, C. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-905oc · Cited by 137
Patient education and counselling for promoting adherence to treatment for tuberculosis
M’Imunya, J. M., Kredo, T., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006591.pub2 · Cited by 132
Dexamethasone in Tuberculous Meningitis
O'Toole, R. D., THORNTON, G. F., MUKHERJEE, M. K., & NATH, R. L. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-39 · Cited by 124
Mortality From Tuberculous Meningitis Reduced by Steroid Therapy
Escobar, J. A. D., Belsey, M. A., Duenas, A. P., & Medina, P. (1975) · PEDIATRICS · doi:10.1542/peds.56.6.1050 · Cited by 112
Effect of pharmacist-led patient education on adherence to tuberculosis treatment
Clark, P. M., Karagöz, T., Apikoğlu-Rabuş, Ş., & İzzettin, F. V. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050543 · Cited by 108
Martins, N., Morris, P. S., & Kelly, P. M. (2009) · BMJ · doi:10.1136/bmj.b4248 · Cited by 103
Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
Jenkins, H. E., Zignol, M., & Cohen, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022927 · Cited by 103
Promoting adherence to tuberculosis treatment
Garner, P. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.035568 · Cited by 97
Liu, Q., Abba, K., Alejandria, M. M., Sinclair, D., Balanag, V. M., & Lansang, M. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006594.pub3 · Cited by 90
Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE
Luetkemeyer, A. F., Kendall, M. A., Nyirenda, M., Wu, X., Ive, P., Benson, C. A., Andersen, J. W., Swindells, S., Sanne, I., Havlir, D. V., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000030 · Cited by 78
Khan, F. A., Minion, J., Almotairi, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis630 · Cited by 74
Iribarren, S., Beck, S. L., Pearce, P. F. F., Chirico, C., Etchevarria, M., Cardinale, D., & Rubinstein, F. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/349394 · Cited by 70
Liefooghe, R., Suetens, C., Meulemans, H., Moran, M. B., & Muynck, A. D. (1999) · PubMed · Cited by 66
Optimal Duration of Anti-TB Treatment in Patients With Diabetes
Wang, J., Lee, M., Shu, C., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0918 · Cited by 65
Aber, V. R., & Nunn, A. (1978) · PubMed · Cited by 65
Automated Telephone Reminders in Tuberculosis Care
Tanke, E. D., & Leirer, V. O. (1994) · Medical Care · doi:10.1097/00005650-199404000-00006 · Cited by 64
Suthar, A. B., Granich, R., Mermin, J., & Rie, A. V. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.093260 · Cited by 63
Material incentives and enablers in the management of tuberculosis
Lutge, E. E., Wiysonge, C. S., Knight, S. E., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007952.pub2 · Cited by 60
Tuberculosis treatment with mobile-phone medication reminders in northern Thailand.
Kunawararak, P., Pongpanich, S., Chantawong, S., Pokaew, P., Traisathit, P., Srithanaviboonchai, K., & Plipat, T. (2011) · PubMed · Cited by 59
Wright, C. M., Westerkamp, L. M., Körver, S., & Dobler, C. C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0945-5 · Cited by 52
Global and Regional Burden of Isoniazid-Resistant Tuberculosis
Yuen, C. M., Jenkins, H. E., Rodriguez, C. A., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2015-0172 · Cited by 46
LoBue, P. A., & Ks, M. (2005) · PubMed · Cited by 35
Experience with adjunctive corticosteroids in managing tuberculous pericarditis.
Reuter, H., Burgess, L. J., Louw, V. J., & Doubell, A. F. (2006) · Cardiovascular journal of South Africa · Cited by 31
Hopewell, P. C., Fair, E., & Uplekar, M. W. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201401-004ar · Cited by 28
Self-citationVisser, M. E., Texeira-Swiegelaar, C., & Maartens, G. (2004) · PubMed · Cited by 23
Krishnaswami, K. V., Somasundaram, P. R., Tripathy, S. P., Vaidyanathan, B., Radhakrishna, S., & Fox, W. (1981) · Tubercle · doi:10.1016/0041-3879(81)90017-9 · Cited by 15
Chang, K. C., & Leung, C. C. (2010) · Clinical Infectious Diseases · doi:10.1086/654806 · Cited by 10
DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
Liu, S. Y., Li, J., & Nw, S. (2005) · PubMed · Cited by 6
Cited by
Point-of-care diagnostics for infectious diseases: From methods to devices
Wang, C., Liu, M., Wang, Z., Li, S., Deng, Y., & He, N. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101092 · Cited by 622
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Dorman, S. E., Nahid, P., Kurbatova, E. V., Phillips, P. P. J., Bryant, K., Dooley, K. E., Engle, M., Goldberg, S. V., Phan, H. T. T., Hakim, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033400 · Cited by 539
Self-citationAnti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Tiberi, S., du Plessis, N., Walzl, G., Vjecha, M. J., Rao, M., Ntoumi, F., Mfinanga, S., Kapata, N., Mwaba, P., McHugh, T. D., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30110-5 · Cited by 396
Self-citationSpinal tuberculosis: a comprehensive review for the modern spine surgeon
Khanna, K., & Sabharwal, S. (2019) · The Spine Journal · doi:10.1016/j.spinee.2019.05.002 · Cited by 273
Metadata
- Authors
- Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., Higashi, J. M., Ho, C. S., Hopewell, P. C., Keshavjee, S. A., Lienhardt, C., Menzies, R., Merrifield, C., Narita, M., O'Brien, R., Peloquin, C. A., Raftery, A., Saukkonen, J., Schaaf, H. S., Sotgiu, G., Starke, J. R., Migliori, G. B., & Vernon, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-09-01
- Volume
- 63
- Issue
- 7
- Pages
- 853-867
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4235935369
- Cited by
- 326
- References
- 69
- FWCI
- 28.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.